Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine nasal spray for preoperative sedation and analgesia in CT-guided lung nodule localization
ChiCTR2500109215Phase 4Not yet recruiting
- Sponsor
- First Affiliated Hospital of Soochow University
- Start
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of dexmedetomidine in preoperative anxiety and postoperative pain (2 arms), sponsored by First Affiliated Hospital of Soochow University. Primary endpoint: Incidence of moderate movement-related pain after lung nodule localization (NRS). Planned start Sep 2025; status: not yet recruiting.
02
Drugs
dexmedetomidine
03
Conditions
preoperative anxietypostoperative pain
Beyond the preview
Go deeper on ChiCTR2500109215.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500109215.